Patent EP4397684A1: Anti-Human TSLP Monoclonal Antibody

ChangeBridge: EPO Bulletin - Peptides (C07K)

Published March 11th, 2026

Detected March 26th, 2026

Summary

The European Patent Office has published patent application EP4397684A1 concerning an anti-human TSLP monoclonal antibody and its use. The application was filed by Qyuns Therapeutics Co., Ltd. and lists multiple inventors.

View original document View source feed page

What changed

This document is a publication of a European patent application (EP4397684A1) for an anti-human TSLP monoclonal antibody and its therapeutic uses, filed by Qyuns Therapeutics Co., Ltd. The publication date is March 11, 2026, and it includes various International Patent Classification (IPC) codes related to antibodies, peptides, and their medical applications.

As this is a patent publication, there are no direct compliance obligations or deadlines for regulated entities. However, it signifies potential new intellectual property in the field of biologics and immunology, which may impact future drug development and market exclusivity for companies operating in the pharmaceutical and biotechnology sectors within the designated European states.

Source document (simplified)

← EPO Patent Bulletin

ANTI-HUMAN TSLP MONOCLONAL ANTIBODY AND USE THEREOF

Publication EP4397684A1 Kind: A1 Mar 11, 2026

Applicants

Qyuns Therapeutics Co., Ltd.

Inventors

QIU, Jiwan, KONG, Yong, CHEN, Wei, QIAO, Huaiyao, WU, Yiliang, CHEN, Tao, WU, Meijuan

IPC Classifications

C07K 16/24 20060101AFI20250129BHEP C12N 15/13 20060101ALI20250129BHEP A61K 39/395 20060101ALI20250129BHEP A61P 37/08 20060101ALI20250129BHEP A61P 11/06 20060101ALI20250129BHEP A61P 17/00 20060101ALI20250129BHEP A61P 11/02 20060101ALI20250129BHEP A61P 1/00 20060101ALI20250129BHEP A61P 27/14 20060101ALI20250129BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →